Total Payments
$330,717
2023 Payments
$1,000
Companies
13
Transactions
481
Medicare Patients
103
Medicare Billing
$16,350
Payment Breakdown by Category
Other$255,354 (77.2%)
Travel$51,860 (15.7%)
Consulting$13,450 (4.1%)
Food & Beverage$10,053 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $255,354 | 113 | 77.2% |
| Travel and Lodging | $51,860 | 183 | 15.7% |
| Consulting Fee | $13,450 | 6 | 4.1% |
| Food and Beverage | $10,053 | 179 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $193,741 | 254 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $122,163 | 168 | $0 (2019) |
| Mylan Specialty L.P. | $8,020 | 17 | $0 (2019) |
| CAIRE Inc. | $5,125 | 5 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $1,072 | 9 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $175.72 | 4 | $0 (2019) |
| GENZYME CORPORATION | $140.16 | 9 | $0 (2021) |
| Mallinckrodt Enterprises LLC | $121.76 | 5 | $0 (2019) |
| GlaxoSmithKline, LLC. | $90.88 | 5 | $0 (2019) |
| Allergan Inc. | $27.81 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,000 | 1 | CAIRE Inc. ($1,000) |
| 2021 | $649.87 | 2 | CAIRE Inc. ($625.00) |
| 2020 | $2,500 | 1 | CAIRE Inc. ($2,500) |
| 2019 | $23,057 | 42 | AstraZeneca Pharmaceuticals LP ($12,272) |
| 2018 | $113,535 | 176 | AstraZeneca Pharmaceuticals LP ($83,248) |
| 2017 | $189,975 | 259 | AstraZeneca Pharmaceuticals LP ($98,221) |
All Payment Transactions
481 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/24/2023 | CAIRE Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 10/28/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Immunology | ||||||
| 06/01/2021 | CAIRE Inc. | — | Consulting Fee | Cash or cash equivalent | $625.00 | General |
| 09/11/2020 | CAIRE Inc. | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| 09/01/2019 | CAIRE Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| 05/27/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Respiratory | ||||||
| 05/20/2019 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Respiratory | ||||||
| 05/15/2019 | Mylan Specialty L.P. | Yupelri (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,628.00 | General |
| Category: Respiratory and Allergy | ||||||
| 05/15/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2019 | Mylan Specialty L.P. | Yupelri (Drug) | Travel and Lodging | Cash or cash equivalent | $526.59 | General |
| Category: Respiratory and Allergy | ||||||
| 05/15/2019 | Mylan Specialty L.P. | Yupelri (Drug) | Travel and Lodging | Cash or cash equivalent | $258.77 | General |
| Category: Respiratory and Allergy | ||||||
| 05/15/2019 | Sunovion Pharmaceuticals Inc. | LONHALA MAGNAIR (Drug) | Food and Beverage | In-kind items and services | $43.73 | General |
| Category: RESPIRATORY | ||||||
| 05/15/2019 | Mylan Specialty L.P. | Yupelri (Drug) | Travel and Lodging | Cash or cash equivalent | $30.00 | General |
| Category: Respiratory and Allergy | ||||||
| 05/14/2019 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Travel and Lodging | In-kind items and services | $651.66 | General |
| Category: Respiratory | ||||||
| 05/14/2019 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Travel and Lodging | In-kind items and services | $206.62 | General |
| Category: Respiratory | ||||||
| 05/14/2019 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $94.90 | General |
| Category: Respiratory | ||||||
| 05/14/2019 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Travel and Lodging | In-kind items and services | $48.61 | General |
| Category: Respiratory | ||||||
| 05/13/2019 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Respiratory | ||||||
| 05/13/2019 | AstraZeneca Pharmaceuticals LP | DALIRESP (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Respiratory | ||||||
| 05/08/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: RESPIRATORY | ||||||
| 05/07/2019 | AstraZeneca Pharmaceuticals LP | DALIRESP (Drug) | Travel and Lodging | In-kind items and services | $499.49 | General |
| Category: Respiratory | ||||||
| 05/07/2019 | AstraZeneca Pharmaceuticals LP | DALIRESP (Drug) | Travel and Lodging | In-kind items and services | $437.45 | General |
| Category: Respiratory | ||||||
| 05/07/2019 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $90.47 | General |
| Category: Respiratory | ||||||
| 05/07/2019 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: Respiratory | ||||||
| 05/07/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 11 | 11 | $4,532 | $1,487 |
| 2020 | 3 | 92 | 156 | $34,400 | $14,863 |
Total Patients
103
Total Services
167
Medicare Billing
$16,350
Procedure Codes
4
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 11 | 11 | $4,532 | $1,487 | 32.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 63 | 117 | $23,400 | $10,111 | 43.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 16 | 19 | $7,600 | $3,603 | 47.4% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 13 | 20 | $3,400 | $1,149 | 33.8% |
About Dr. Keith Robinson, MD
Dr. Keith Robinson, MD is a Critical Care Medicine healthcare provider based in Oakland Park, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407828015.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Keith Robinson, MD has received a total of $330,717 in payments from pharmaceutical and medical device companies, with $1,000 received in 2023. These payments were reported across 481 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($255,354).
As a Medicare-enrolled provider, Robinson has provided services to 103 Medicare beneficiaries, totaling 167 services with total Medicare billing of $16,350. Data is available for 2 years (2020–2022), covering 4 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Oakland Park, FL
- Active Since 02/07/2006
- Last Updated 12/05/2019
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407828015
Products in Payments
- BEVESPI AEROSPHERE (Drug) $156,145
- UTIBRON (Drug) $82,890
- SYMBICORT (Drug) $35,606
- LONHALA MAGNAIR (Drug) $29,902
- BROVANA (Drug) $9,272
- Yupelri (Drug) $7,983
- DALIRESP (Drug) $1,937
- ACTHAR (Biological) $121.76
- DUPIXENT (Drug) $115.29
- LATUDA (Drug) $79.58
- ANORO (Drug) $46.98
- STIOLTO (Drug) $37.20
- OPSUMIT MACITENTAN (Drug) $28.39
- DUPIXENT (Biological) $24.87
- BREO (Drug) $23.94
- TRELEGY ELLIPTA (Drug) $19.96
- FASENRA (Drug) $19.08
- Utibron (Drug) $18.22
- SMARTVEST (Device) $16.00
- TEFLARO (Drug) $14.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.